Daiwa Securities Group Inc. Amgen Inc Transaction History

Daiwa Securities Group Inc.

$21.6 Billion
Q3 2024

A detailed history of Daiwa Securities Group Inc. transactions in Amgen Inc stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 182,475 shares of AMGN stock, worth $48.2 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

182,475

Previous 169,543 7.63%

Holding current value

$48.2 Million

Previous $53 Million 10.99%

% of portfolio

0.27%

Previous 0.28%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$309.38 - $337.38 $4 Million - $4.36 Million	12,932 Added 7.63%	182,475 $58.8 Million
Q2 2024 Aug 07, 2024	BUY	$262.75 - $319.31 $2.73 Million - $3.31 Million	10,374 Added 6.52%	169,543 $53 Million
Q1 2024 May 02, 2024	BUY	$268.87 - $324.56 $2.61 Million - $3.15 Million	9,705 Added 6.49%	159,169 $45.3 Million
Q4 2023 Jan 31, 2024	SELL	$255.7 - $288.46 $317,835 - $358,555	-1,243 Reduced 0.82%	149,464 $43 Million
Q3 2023 Nov 01, 2023	BUY	$218.65 - $271.46 $4.14 Million - $5.15 Million	18,957 Added 14.39%	150,707 $40.5 Million
Q2 2023 Jul 31, 2023	BUY	$214.27 - $253.37 $339,832 - $401,844	1,586 Added 1.22%	131,750 $29.3 Million
Q1 2023 May 02, 2023	BUY	$225.79 - $275.2 $2.46 Million - $3 Million	10,917 Added 9.15%	130,164 $31.5 Million
Q4 2022 Feb 06, 2023	BUY	$229.03 - $291.01 $810,079 - $1.03 Million	3,537 Added 3.06%	119,247 $31.3 Million
Q3 2022 Nov 02, 2022	BUY	$224.46 - $253.15 $1.45 Million - $1.63 Million	6,457 Added 5.91%	115,710 $26.1 Million
Q2 2022 Aug 09, 2022	BUY	$230.71 - $256.74 $892,847 - $993,583	3,870 Added 3.67%	109,253 $26.6 Million
Q1 2022 Apr 29, 2022	BUY	$219.27 - $242.57 $1.18 Million - $1.31 Million	5,391 Added 5.39%	105,383 $25.5 Million
Q4 2021 Feb 03, 2022	BUY	$198.88 - $227.6 $1.29 Million - $1.48 Million	6,484 Added 6.93%	99,992 $22.5 Million
Q3 2021 Nov 05, 2021	BUY	$212.27 - $248.7 $795,587 - $932,127	3,748 Added 4.18%	93,508 $19.9 Million
Q2 2021 Aug 06, 2021	BUY	$233.58 - $259.14 $930,816 - $1.03 Million	3,985 Added 4.65%	89,760 $21.9 Million
Q1 2021 May 03, 2021	SELL	$221.91 - $258.6 $227,235 - $264,806	-1,024 Reduced 1.18%	85,775 $21.3 Million
Q4 2020 Feb 04, 2021	BUY	$216.38 - $257.67 $741,534 - $883,035	3,427 Added 4.11%	86,799 $20 Million
Q3 2020 Nov 02, 2020	BUY	$234.65 - $260.95 $10.4 Million - $11.6 Million	44,299 Added 113.37%	83,372 $21.2 Million
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $24,602 - $32,629	135 Added 0.35%	39,073 $7.92 Million
Q4 2019 Jan 31, 2020	BUY	$189.21 - $243.2 $168,396 - $216,448	890 Added 2.34%	38,938 $9.39 Million
Q3 2019 Nov 04, 2019	BUY	$174.11 - $208.62 $44,920 - $53,823	258 Added 0.68%	38,048 $7.36 Million
Q2 2019 Jul 24, 2019	SELL	$166.7 - $195.41 $4.1 Million - $4.81 Million	-24,593 Reduced 39.42%	37,790 $6.96 Million
Q1 2019 Apr 26, 2019	BUY	$180.87 - $203.88 $4.39 Million - $4.95 Million	24,292 Added 63.77%	62,383 $11.9 Million
Q4 2018 Feb 05, 2019	SELL	$178.4 - $208.25 $88,308 - $103,083	-495 Reduced 1.28%	38,091 $7.42 Million
Q3 2018 Nov 01, 2018	BUY	$185.29 - $208.89 $256,256 - $288,894	1,383 Added 3.72%	38,586 $8 Million
Q2 2018 Jul 30, 2018	SELL	$166.05 - $186.51 $16,106 - $18,091	-97 Reduced 0.26%	37,203 $6.87 Million
Q1 2018 May 02, 2018	SELL	$169.43 - $198.0 $217,378 - $254,034	-1,283 Reduced 3.33%	37,300 $6.36 Million
Q4 2017 Feb 06, 2018	SELL	$168.79 - $188.59 $173,009 - $193,304	-1,025 Reduced 2.59%	38,583 $6.71 Million
Q3 2017 Nov 02, 2017	BUY	$167.29 - $191.0 $6.63 Million - $7.57 Million	39,608	39,608 $7.39 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.

Account

Daiwa Securities Group Inc. Amgen Inc Transaction History